General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Campana R et al. – The minimal inhibitory concentrations (MICs) of EEPs and flavonoids for C. jejuni isolates were determined by the agar dilution method. EEPs showed MIC values of 0.3125–0.156mg/mL for all C. jejuni strains; galangin and quercetin gave MICs ranging from 0.250 to 0.125mg/mL. Thus propolis preparations could be used as support to traditional therapy for Campylobacter infection, especially when the antibiotic agents show no activity against this microorganism.

Related Articles

Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohns disease
Inflammatory Bowel Disease, 11/05/09    Relevance Score: 68%

Comparison of basal broth media for the optimal laboratory recovery of Campylobacter jejuni and Campylobacter coli
Irish Journal of Medical Science, 11/09/09    Relevance Score: 67%

Outer membrane vesicle-mediated release of cytolethal distending toxin from Campylobacter jejuni
BMC Microbiology, 10/21/09    Relevance Score: 67%

AI-2 does not Function as a Quorum Sensing Molecule in Campylobacter jejuni during exponential growth in vitro
BMC Microbiology, 10/12/09    Relevance Score: 67%

Campylobacter jejuni abscess, encephalomyelitis, and acute polyradiculoneuropathy
Muscle & Nerve, 10/07/09    Relevance Score: 67%

Today in Antimicrobials...keeping you current

Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09

Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09

Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address